Latest CancerVax Stories
OXFORD, England, April 20, 2015 /PRNewswire/ -- IMCgp100 shows partial and complete durable responses in Phase I/IIa trial in
OXFORD, England, April 8, 2015 /PRNewswire/ -- ~ A Phase I/IIa study of IMCgp100: partial and complete durable responses with a novel first-in-class
SAN DIEGO, Feb. 4, 2015 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
Vaccine & Gene Therapy Institute of Florida to provide expertise in vaccine development and clinical trial design SEATTLE, Nov. 18, 2014 /PRNewswire/ --TapImmune, Inc.
Management Responds To Inquiries Concerning Discovery Capabilities For Anti-Ebola Treatments SAN DIEGO, Oct. 21, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
SAN DIEGO, Oct. 10, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
LONDON, Oct. 2, 2014 /PRNewswire/ -- This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy.
SAN DIEGO, Sept. 25, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (OTCQB: TELKD), a clinical stage oncology drug development company, announced today that the U.S.
LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- The abrogation of a law by a higher authority; annulment.
- In music, during the eighteenth century, a song or an instrumental piece similar to the serenade, intended for performance in the open air.